Does Rallies track congressional trades in CVS?

Yes. Rallies tracks politician and congressional stock disclosures for CVS, including reported purchases, sales, dates, owners, and trade amounts when available.

Is CVS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CVS. It does not provide personalized investment advice.

CVS (CVS Health) Stock Analysis - Politician Trades

CVS Health (CVS) is a publicly traded Healthcare sector company. As of May 20, 2026, CVS trades at $93.25 with a market cap of $122.48B and a P/E ratio of 14.37. CVS moved -0.73% today. Year to date, CVS is +17.53%; over the trailing twelve months it is +50.02%. Its 52-week range spans $43.56 to $98.43. Analyst consensus is strong buy with an average price target of $102.35. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded CVS stock?

Recent politician trading activity in CVS includes disclosures from John Boozman, Michael McCaul, Dwight Evans, Val Hoyle, and Adam Smith. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

CVS Key Metrics

Key financial metrics for CVS
Metric	Value
Price	$93.25
Market Cap	$122.48B
P/E Ratio	14.37
EPS	$6.49
Dividend Yield	0.67%
52-Week High	$98.43
52-Week Low	$43.56
Volume	6.00M
Avg Volume	0
Revenue (TTM)	$357.78B
Net Income	$8.37B
Gross Margin	39.32%

Congressional Trades in CVS

John Boozman purchase CVS on Jan 29, 2026 (amount: $15.00K) for Joint.
Michael McCaul sale CVS on Jan 13, 2026 (amount: $50.00K) for Spouse.
Dwight Evans sale CVS on Nov 21, 2025 (amount: $15.00K).
Val Hoyle sale CVS on Sep 23, 2025 (amount: $15.00K) for Spouse.
Adam Smith sale CVS on Aug 8, 2025 (amount: $15.00K) for Spouse.

Latest CVS News

CVS Health Invests $292M in Veteran-Owned Businesses and Expands Military Family Programs — May 20, 2026
CVS Health invests $20 billion in digital health tools after survey finds 58% of seniors struggle — May 18, 2026
CVS Health, WGU Launch Online Pre-Pharmacy Program with $3,989 Term Tuition — May 14, 2026
MinuteClinic Weight-Loss Program Posts 85% Three-Month Success Across 49 States, Primary Care at 60% of Clinics — May 13, 2026
CVS jumps as TD Cowen lifts price target to $110, keeps buy — May 12, 2026

Recent CVS Insider Trades

Mandadi Tilak sold 69.55K (~$6.23M) on May 8, 2026.
Finucane Anne A. sold 7.50K (~$532.65K) on Aug 20, 2025.
SANSONE GUY P bought 1.57K (~$100.01K) on Jun 5, 2025.

CVS Analyst Consensus

17 analysts cover CVS: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.35.

Common questions about CVS

Which politicians traded CVS stock?: Recent politician trading activity in CVS includes disclosures from John Boozman, Michael McCaul, Dwight Evans, Val Hoyle, and Adam Smith. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in CVS?: Yes. Rallies tracks politician and congressional stock disclosures for CVS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CVS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CVS. It does not provide personalized investment advice.